Netherlands· NL-3f60aff16a62

Mitomycine Accord 40 mg, poeder voor oplossing voor injectie/infusie

A mitomycin product containing mitomycine, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 17 of our 19 countries.

ATC L01DC03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mitomycineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mitomycin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01DC03 (mitomycin), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search mitomycin products by name

Mitomycin · ATC L01DC03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mitomycin costs, country by country.

Normalised to the WHO defined daily dose (4.29 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mitomycin · price per daily dose (4.29 mg)

USD · FX 28 Sept 2026

CH Switzerland$32.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MITOMYCINE
Manufacturer: Accord Healthcare B.V.
Country: Netherlands (NL)
ATC code: L01DC03
ATC class: Mitomycin
Defined daily dose: 4.29 mg, intravesikal
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
119217

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

193 interactions on record for mitomycin.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check mitomycin against other medicines How interaction checks work

Mitomycin · interactions on record

193 records

31 severe
101 moderate
15 minor
46 info

Most severe, free to view

CladribineL01BB04severe
FluorouracilL01BC02severe
Talimogene laherparepvecL01XL02severe
Talimogen laherparepvecL01XX51severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mitomycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mitomycin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Mitomycin Medac
Belgium · Mitomycin Accord Healthcare, Mitomycin Medac
Bulgaria · Митомицин Акорд
Cyprus · Mitomycin Accord, Mitomycine Substipharm
Czechia · Mitomycin Accord, Mitomycin Medac
Germany · Mitem, Mito-Apogepha
Denmark · Mitomycin Medac
Estonia · Mitomycin Accord, Mitomycin Medac
Spain · Mitomicina Accord, Mitomicina Aurovitas
Finland · Mitomycin Accord, Mitomycin Medac
France · Mitomycine Accord, Mitomycine Medac
United Kingdom (Northern Ireland) · Mitocin, Mitomycin Accord Healthcare
Ireland · Mitomycin Medac
Iceland · Mitomycin Medac
Italy · Mitomicina Accord, Mitomicina Medac
Lithuania · Mitomycin Medac
Latvia · Mitomycin Medac
Malta · Mitomycine Substipharm
Norway · Mitomycin Medac, Mitomycin Substipharm
Poland · Mitomycin Accord
Portugal · Mitomicina Accord, Mitomicina Accord Healthcare
Romania · Mitomicină Accord
Sweden · Mitomycin Medac, Mitomycin Substipharm
Slovenia · Mitomicin Accord, Mitomicin Medac
Slovakia · Mitomycin Accord, Mitomycin Medac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bcdaf445-4c52-46c1-899f-de4d4bf48d17
GET /v1/drugs/bcdaf445-4c52-46c1-899f-de4d4bf48d17?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor oplossing voor injectie of infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h119217_smpc.pdf",
  "strength": null,
  "atc_label": "Mitomycin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg119217",
  "excipients": [
    "MANNITOL (D-) (E 421)",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "MITOMYCINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h119217.pdf",
  "authorised_at": "2017/10/09",
  "procedure_number": "NL/H/3767/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "119217",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about mitomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console